Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Most definitely.
We can speculate all we want. If anyone thinks insiders are selling and that is a concern then why not just sell and move on? The speculation of insider selling or without solid facts is is just that, speculation. Show me who has sold what and then we can evaluate. Beyond that I am waiting for NEI news and the IND news.
They had the shell warning symbol at some point and it ain’t there now, and has not been for a while. That’s all I know.
The company used to have the shell symbol in the OTC markets and was eventually removed.
Added more shares this week in the mid 5’s. Price here is a gift imo as we wait on news/communication on a research agreement with the NIH. CEO’s last blog mentioned this. Doubt insiders have been selling at this level.
Yeah Angela Merkel. Say no more.
Back to the wife beating schtick eh? Someone here needs some new material. LOL.
Here we go again. Beating a dead horse on insider selling.
Wonder if people were wondering if Jennifer Cook was pimpin chit at Gyroscope Therapeutics as a board member and advisor after the company announced they they were being purchased for $1.5 Billion. Kinda doubt it. LOL. CUBT Board and CEO Advisor Catherine Sohn is not pimpin anything. They are in one of the same businesses as CUBT in combatting age-related macular degeneration (AMD) and Catherine and Jennifer are both board members at Jazz Pharmaceuticals. AMD is a multi billion dollar opportunity. Stay tuned. Long CUBT.
But then again it might. I wasn’t drawing any conclusion. I just found it interesting for my wondering mind and thought I would share. Merry Christmas to all!
I can’t help but wonder if bears called Jennifer cook arm candy, you know since she is a Board Member to Gyroscope Therapeutics, and not a “full time employee”. LOL.
Here’s a little tid bit for wondering minds…
If you look up Jennifer Cook on LinkedIn you will find that she is a high powered executive. You will also find she is a Board Member of Gyroscope Therapeutics, the company that was just purchased by Novartis for $1.5B, which CUBT Chairman Paul Michaels posted about today. If you look closely at her bio you will also notice she is a board member of Jazz Pharmaceuticals. Guess who else is a Board Member of Jazz Pharmaceuticals? Yeah, CUBT’s very own Catherine Sohn, Advisor to the CEO and the CUBT Board. Hmmmmm. I wonder if they ever chat about being Board members of companies trying to create solutions for AMD? My guess is that they have had a chat or two. Where does it all lead? Stay tuned.
Do I sense a hint of sarcasm here? LOL.
I would prefer that as well. Just taking a guess here. Hopefully they will go your direction.
That would assume they do a RS at .05. I don’t they will do a RS at these prices. If and when they do a RS to uplist my estimate would be in the 1:20 range.
i Robot I’m liking more of your posts recently! Totally agree.
Completely disagree. Most people have not connected the dots. And what is coming through this collab is not baked into the price. The beauty of the free market system is we are free to disagree. Kind of like there zero evidence of insider selling. LOL.
I doubt insiders are selling. Once they announce the collaboration with the NEI which CEO Garr has been working on the stock price will move. Doubt any insiders are selling knowing what is coming.
AMD is a big problem in our aging population for sure. Combine this with the Metformin Press Release last week by the NIH. The work is being lead by Dr. Bharti. Not sure how much more clear it needs to be. CUBT is in the middle of it all with the same Dr. Bharti leading the way on CUBT’s Metformin eye drop. Connect the dots. News is coming.
CUBT very good read. It’s long and small print but lots of good information, particularly around AMD. The devil is always in the details.
CUBT will be part of the NEI strategic plan moving forward. Count on it.
https://www.nei.nih.gov/sites/default/files/2021-12/NEI-StrategicPlan-VisionForTheFuture_508_edit.pdf
People are sleeping on this gem.
The thought that insiders are selling shares at this price given what they have in the pipeline is so ridiculous it’s not even worth arguing the point. If anyone thinks insiders are selling here should really sell their shares imo.
Sure they have brought the price down, mostly on days where the volume is frequently 1/10th to 2/10ths of ONE PERCENT of the outstanding shares. Patience will pay off.
Maybe not smiling but buying? Absolutely!!!
Filled a few at .057. I’ll take it.
Yes they are missing the point. I expect an update from the company soon on Metformin. The NEI has begun the work. It’s happening and people don’t see it.
It is a great loading zone. I agree.
Manipulation through and through. So I put a bid in .003 above ask yet they fill lower. Why on earth would anyone not take the higher price? It’s market maker manipulation to hold price down. Period.
400,000 shares is not a lot of volume on the number of shares outstanding. And today up 34% on 974K. It’s coming.
Totally agree! Things are about to get exciting!
I can only laugh at the bears here who have basically been saying CUBT’s world class group of Advisors (like Dr. Bharti) are nothing more than “arm candy”. It’s laughable. Dr. Bharti has been working primarily on repurposing diabetes drug Metformin, one of the most prescribed drugs in the WORLD, to treat eye diseases like AMD and L-ORD. This is his passion and life work at the moment.
Do not be fooled by comments here that end in “wink wink” or “Bwahaaaaaaa” (still trying to figure out what this one means).
Connect the dots people! It’s coming.
Connecting the dots no doubt.
Any news update from the company on their Metformin (eye drops) eye disease solution which is being lead by CUBT’s very own Advisor Dr. Bharti will be HUGE.
This is the same Dr. Bharti from the NEI who lead the investigators in the NEI study which was press released YESTERDAY by the NIH here:
https://www.nih.gov/news-events/news-releases/nih-study-traces-molecular-link-gene-late-onset-retinal-degeneration
“The investigators were led by Kapil Bharti, Ph.D., who directs the NEI Ocular and Stem Cell Translational Research Section”
Connecting the dots indeed! Things are about to get exciting!
This is a big deal! Dr. Bharti whom CUBT is working with on the Metformin eye drop led the investigators in this study. That’s significant. Nice PR from the National Institute of Health!!
A reverse split here to just get on a higher exchange would be a bad strategic move.
You were right on the .05’s. Anything in the .03’s and I’ll add several hundred thousand shares if I can pull it off. Been chipping away with small adds but that level will bring heavy buying.
Added some at .056 today.
Added a few at .058. If it goes lower I will buy more.
Today it’s the market makers that are buying up the cheap shares imo. And me too. I’m adding. I know of at least one investor who was looking to sell for tax related matters. Either way, I’m buying in the .05’s.
Tax loss seller. And I’m a buyer. Added here in the .05’s. Market makers won’t be the only ones stealing shares at this price.
Totally agree. Completely different business model than prior company which focused on ALS stem cell work, which is a long, arduous road. I love this model focusing on underserved, rare diseases with a two year targeted time frame for monetization.
Very important posting by the NIH on LinkedIn below. They are looking for human trial participants for a possible treatment for Stargardt’s Disease.
Remember Dr. Kapil Bharti is the inventor of the solution here and works for the NIH.
https://www.linkedin.com/posts/national-eye-institute-nei_stargardt-activity-6867144437303169024-BrGJ
And now take a look at one of the indications on the Curative Pipeline. You guessed it, one of the indications is Stargardt’s disease. Could this human trial be with Metformin? Very much possible imo.
https://curativebiotech.com/pipeline
Connect the dots…